Hair

Minoxidil: the research history.

Minoxidil appears in topical and oral hair formulations. Its research history crosses two treatment routes and several diagnoses, so the dose, population and outcome belong alongside every result.

2,977records matching the ingredient search

3connected formulations

9displayed publication records

How the research connects to the formula

The catalog pairs topical minoxidil with finasteride and oral minoxidil with either finasteride or spironolactone. These combinations make a useful starting point for a formulation map: hold the minoxidil route constant, then compare the companion ingredient and its own evidence.

The displayed trials use 1 mg and 5 mg oral regimens, and 5% topical minoxidil. A comparison with the catalog must retain those differences, including the 6% topical combination and the separate oral companion ingredients.

Current HealthRX.com formulation map
Product	Listed formulation	Connected ingredient research
Minoxidil 6% / Finasteride 0.1% Topical	Minoxidil 6% / Finasteride 0.1%	Minoxidil · Finasteride
Minoxidil 1mg / Spironolactone 60mg	Minoxidil 1mg / Spironolactone 60mg	Minoxidil · Spironolactone
Minoxidil 1mg / Finasteride 1.25mg	Minoxidil 1mg / Finasteride 1.25mg	Minoxidil · Finasteride

Publication history

When the ingredient appeared in the literature

The chart counts records mentioning the search terms in their title or abstract. It includes research beyond hair. Use the period controls to inspect the count.

2026: 191 indexed publications. 2026 includes publications dated through October 5. The earlier bars cover longer periods than the annual bars.

View the chart as a data table

Period	Publications
1900-1959	0
1960-1969	0
1970-1979	132
1980-1989	497
1990-1999	351
2000-2009	283
2010-2014	186
2015-2019	313
2020	128
2021	96
2022	141
2023	166
2024	204
2025	289
2026	191

Search query and data source

Source: Europe PMC’s PubMed-indexed records. Retrieved October 5, 2026. The index’s firstPublicationDate field supplies the dates and chart periods; it can normalize a month-only record to the first day of the month. Dates through October 5 are included. Counts can change as the index adds or corrects records.

TITLE_ABS:(minoxidil) AND SRC:MED AND FIRST_PDATE:[1900-01-01 TO 2026-10-05]

Open this literature search · Download the data

Dated publications

Read individual records in context

The timeline combines selected references with a sample from the ingredient search. Dates use the index’s firstPublicationDate field; the PubMed record may distinguish an earlier online date from the print date. Written study notes appear alongside the records that have them. Other entries show the indexed bibliography and link to the paper.

Controlled Clinical Trial · Comparative Study · Clinical Trial · Journal Article

Topical minoxidil for hair regrowth.

Vanderveen EE, Ellis CN, Kang S, Case P, Headington JT, Voorhees JJ, Swanson NA. Journal of the American Academy of Dermatology. PMID 6384289.

Study design: Small human study, 15 participants
What was tested: Topical minoxidil for 12 months; five participants had androgenetic alopecia and ten had alopecia areata.
What was reported: Regrowth occurred in three of five participants with androgenetic alopecia and none of the ten with alopecia areata.
How it connects to the catalog: A small early study of two different diagnoses. Its results do not establish the response rate for current oral or combination products.

Read the PubMed record · Publisher record

From hypertension treatment to topical hair-loss products

1979-08-18

Oral minoxidil approved in the US for hypertension

Loniten’s approval belongs to oral hypertension treatment. It is a separate event from the later topical hair-loss approvals.

1988-08-17

Topical Rogaine approved in the US

The FDA review records the approval date for topical treatment of alopecia.

1996-02-09

Rogaine 2% moves from prescription to over-the-counter status

The change applies to the documented topical product. It does not describe oral minoxidil or every compounded combination.

FDA historical pharmacology review

Study comparison

Publication	Design and regimen	Reported finding	Interpretation
1984-09-01: Topical minoxidil for hair regrowth.	Small human study, 15 participants. Topical minoxidil for 12 months; five participants had androgenetic alopecia and ten had alopecia areata.	Regrowth occurred in three of five participants with androgenetic alopecia and none of the ten with alopecia areata.	A small early study of two different diagnoses. Its results do not establish the response rate for current oral or combination products.
2021-02-24: Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.	Retrospective multicenter study, 1,404 patients. Low-dose oral minoxidil in clinical practice.	The paper describes reported adverse events in a large treated cohort.	There was no randomized untreated comparison group. This cohort answers a different question from a trial comparing oral and topical treatment.
2023-11-29: Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial.	Randomized trial, 65 patients. Oral minoxidil 1 mg versus topical minoxidil 5%, over six months.	The reported between-group differences were not statistically significant.	That result does not prove the treatments equivalent. The oral dose also differs from the 5 mg trial published in 2024.
2024-06-01: Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.	Randomized trial, 90 enrolled; 68 completed. Oral minoxidil 5 mg daily versus topical minoxidil 5% twice daily in men, over 24 weeks.	Oral treatment did not demonstrate overall superiority over topical treatment.	These results describe the tested single-ingredient regimens. They do not establish results for a 1 mg oral minoxidil and finasteride blend.

Questions that shape the comparison

Did the trial compare routes at the same follow-up time? Was its endpoint hair diameter, terminal hair density, photographic assessment or a patient rating?

Source records

Topical minoxidil for hair regrowth.Vanderveen EE, Ellis CN, Kang S, Case P, Headington JT, Voorhees JJ, Swanson NA.Journal of the American Academy of Dermatology. 1984-09-01. PMID 6384289. Controlled Clinical Trial, Comparative Study, Clinical Trial, Journal Article.

Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones ÓM, Saceda-Corralo D, Rodrigues-Barata R, Jimenez-Cauhe J, Koh WL, Poa JE, Jerjen R, Trindade de Carvalho L, John JM, Salas-Callo CI, Vincenzi C, Yin L, Lo-Sicco K, Waskiel-Burnat A, Starace M, Zamorano JL, Jaén-Olasolo P, Piraccini BM, Rudnicka L, Shapiro J, Tosti A, Sinclair R, Bhoyrul B.Journal of the American Academy of Dermatology. 2021-02-24. PMID 33639244. Multicenter Study, Journal Article.

Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial.Asilian A, Farmani A, Saber M.Journal of cosmetic dermatology. 2023-11-29. PMID 38031516. Randomized Controlled Trial, Journal Article.

Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.Penha MA, Miot HA, Kasprzak M, Müller Ramos P.JAMA dermatology. 2024-06-01. PMID 38598226. Comparative Study, Research Support, Non-U.S. Gov't, research-article, Randomized Controlled Trial, Journal Article.

Effect of topical nanoemulsion of minoxidil on animal hair growth: an in vivo study.Landi FS, Gholami M, Abdollahzadeh N, Esmaeili F, Amani A.Journal of materials science. Materials in medicine. 2026-06-25. PMID 42347998. research-article, Journal Article.

Ocular Events Temporally Associated With Minoxidil: A Structured Review.Akiska YM, Boginskaya O, Mumtaz A, Sibbald C, Ali A.Journal of cutaneous medicine and surgery. 2026-09-06. PMID 42702847. Review, Journal Article.

OMW: Niedrig dosiertes orales Minoxidil.Beyer K.Dermatologie (Heidelberg, Germany). 2026-09-29. PMID 42808991. Journal Article.

Circadian rhythm and minoxidil: avenues for further investigation.Maas D, Spindler A, Zappi I, Cote M, Kantor J, Patel E, Go S, Ahearn IM, Tattersall IW, Petukhova L, Shapiro J, Lo Sicco KI.The British journal of dermatology. 2026-09-30. PMID 42812121. Journal Article.

Daytime oral minoxidil: a new question, and an open mechanism.Sareen J, Donovan J.The British journal of dermatology. 2026-09-30. PMID 42811737. Journal Article.

Research data assembled by HealthRX.com from the displayed source records, October 5, 2026. The atlas contains a dated literature search and selected studies; it is not an exhaustive systematic review.